Method for obtaining mouse hepatocytes

Through the ex vivo liver perfusion and digestion method of mice, combined with the use of type I collagenase and DNA enzyme, the complex problems of mouse liver cell isolation methods were solved, efficient and simple cell separation was achieved, and the high cell viability rate was ensured. and purity, suitable for multiple mice in laboratory operation.

CN118909924APending Publication Date: 2024-11-08SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411153171.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-21
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing methods for isolating liver cells in mice are complex, cumbersome, and the experimental conditions are high, making it difficult to obtain hepatocytes of high purity and viability.

Method used

Extraviolet mouse liver perfusion method was used, and centrifuged after perfusion and digestion was performed. Tissue digestion was performed using type I collagenase digestion solution and DNase I solution to ensure the separation purity and viability of liver cells and simplify the operation process.

Benefits of technology

It achieves efficient and simple separation of mouse liver cells, and the cell viability and morphology are not much different from the existing methods. It is suitable for the operation of multiple mice in the laboratory, making it convenient for subsequent sequencing analysis and culture.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909924A_ABST
    Figure CN118909924A_ABST
Patent Text Reader

Abstract

The invention discloses a method for obtaining mouse hepatocytes, and belongs to the technical field of liver obtaining. When the I-type collagenase digestive juice is rapidly injected into the isolated mouse liver for a short time by using an injector to wash the liver, the mouse liver tissue is loosened, and liver cells are easily separated from the tissue; then digesting the in-vitro mouse liver tissue by adopting a mixed solution of I-type collagenase digestive juice and a DNA enzyme I solution, so that the cells are not easy to agglomerate while the liver cells are separated from the tissue; and finally, carrying out low-speed centrifugation on the digested mouse liver tissues to obtain the mouse liver cells. According to the method, in-vitro perfusion and digestion after perfusion are adopted, the problems that an existing mouse hepatocyte separation method is complex and not easy to operate are solved, and it can be guaranteed that the mouse hepatocytes are successfully obtained.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of liver acquisition, and in particular relates to a method for acquiring mouse liver cells. Background Art

[0002] The liver is one of the most important organs for maintaining life and is the largest internal organ in the human body. Hepatocytes are the most important parenchymal cells in the liver, accounting for about 80% of the liver volume. They perform the main biological functions of the liver, including metabolism, detoxification, protein synthesis, and regulation of energy metabolism. Hepatocyte damage caused by any reason will affect these functions of the liver to varying degrees. Therefore, it is necessary to study liver function by effectively isolating hepatocytes.

[0003] The conventional method of isolating hepatocytes is to perfuse the mouse liver in vivo while the mouse is anesthetized to obtain hepatocytes. However, the experimental conditions required for in vivo perfusion are relatively complex and the operation is cumbersome, and the isolation of mouse hepatocytes is usually limited by experimental conditions. Summary of the invention

[0004] In order to overcome the above-mentioned shortcomings of the prior art, the purpose of the present invention is to provide a method for obtaining mouse hepatocytes, so as to solve the complex technical problems of the existing mouse hepatocyte separation methods.

[0005] In order to achieve the above object, the present invention adopts the following technical solutions:

[0006] The first aspect of the present invention discloses a method for obtaining mouse hepatocytes, comprising the following steps:

[0007] 1) perfusing an isolated mouse liver until the mouse liver turns white, thereby obtaining a whitened mouse liver;

[0008] 2) digesting the blanched mouse liver to obtain digested mouse liver tissue;

[0009] 3) The digested mouse liver tissue is separated and the precipitate is collected by centrifugation to obtain mouse hepatocytes.

[0010] Preferably, in step 1), before perfusion, the hepatic arteriovenous plexus of the mouse is clamped.

[0011] Preferably, in step 1), the perfusion fluid is type I collagenase digestion fluid.

[0012] Further preferably, the formula of type I collagenase digestion solution is: add 1190 mg of HEPES and 280 mg of CaCl2 to 500 mL of HBSS buffer and mix well to obtain tissue digestion buffer; add 5 mg of collagenase I to every 10 mL of tissue digestion buffer to obtain type I collagenase digestion solution.

[0013] Preferably, in step 1), the perfusion solution is perfused into the middle part of each lobe of the isolated mouse liver.

[0014] Further preferably, in step 1), perfusion is performed using a syringe.

[0015] Further preferably, in step 1), the penetration depth of the syringe is 1 / 2 of the thickness of the liver lobe.

[0016] Preferably, in step 2), before digestion, the excess tissue of the blanched mouse liver is removed, and the remaining liver tissue is fully minced until no obvious tissue chunks are visible to the naked eye.

[0017] Further preferably, in step 2), the excess tissue of the bleached mouse liver is removed in a mixture of type I collagenase digestion solution and DNase I solution, and the remaining liver tissue is fully chopped until no obvious tissue blocks are visible to the naked eye.

[0018] Preferably, in step 2), the blanched mouse liver is digested with a mixture of type I collagenase digestion solution and DNase I solution.

[0019] Further preferably, in step 2), in the mixed solution, the volume ratio of type I collagenase digestion solution to DNase I solution is 100:1.

[0020] Further preferably, the formula of type I collagenase digestion solution is: add 1190 mg of HEPES and 280 mg of Cacl2 to 500 mL of HBSS buffer and mix well to obtain tissue digestion buffer; add 5 mg of collagenase I to every 10 mL of tissue digestion buffer to obtain type I collagenase digestion solution; the formula of DNase I solution is: add 20 mg of DNase I to 10 mL of GBSS and fully dissolve it to obtain DNase I solution.

[0021] Preferably, in step 3), the separation step is: centrifuging to remove the supernatant, repeating the steps of adding DMEM and DNase I solution, centrifuging and washing, discarding the supernatant, retaining the precipitate, and obtaining mouse hepatocytes.

[0022] Compared with the prior art, the present invention has the following beneficial effects:

[0023] The present invention provides a method for obtaining mouse hepatocytes, 1) using the liver ex vivo perfusion method to separate mouse primary hepatocytes, which is simple and easy to operate, has low requirements on laboratory conditions, and does not require additional connection of perfusion tubes and peristaltic pumps for perfusion. 2) Before separation, the whitened mouse liver is fully digested, which can overcome the problem that ex vivo perfusion cannot ensure sufficient digestion of liver tissue, and improve the purity and viability of the separated hepatocytes. Experiments have shown that the cell viability and morphology of the hepatocytes obtained by this method are not much different from those obtained by in vivo perfusion of the liver. The mouse hepatocytes are in good growth state, and most of the attached cells are mouse hepatocytes, indicating that the method can successfully separate mouse hepatocytes, and it is expected that this operation can be performed continuously or simultaneously on multiple mice, becoming a simple and easy-to-operate method for obtaining mouse hepatocytes in the laboratory. This makes it easy to separate mouse hepatocytes when a large number of animals are required for the experiment, and to conduct subsequent sequencing analysis and culture and other experiments.

[0024] Furthermore, during perfusion, the hepatic arteriovenous plexus of the mouse was clamped to form a nearly closed perfusion environment to ensure adequate perfusion.

[0025] Furthermore, there is no need to perfuse EGTA solution additionally, and only one perfusion of type I collagenase digestion solution can ensure sufficient perfusion of the mouse liver.

[0026] Furthermore, perfusion is performed in the middle part of each lobe of the isolated mouse liver, which ensures that the red blood cells are flushed away while loosening the liver parenchymal cells, making it easy to separate the mouse liver cells from the tissue; the operation is simple and efficient.

[0027] Furthermore, type I collagenase digestion solution and DNase I solution are used simultaneously for in vitro digestion to disperse the cells while preventing cell aggregation caused by DNA; at the same time, it is ensured that in the subsequent low-speed centrifugation process, liver cells with a higher cell density are easier to precipitate than other cells. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 The figure is a comparison chart of the cell viability of mouse hepatocytes obtained by in vitro perfusion separation of the present invention and mouse hepatocytes obtained by in vivo perfusion separation of the existing method; wherein A is the mouse hepatocytes obtained by in vitro perfusion separation of the present invention, B is the mouse hepatocytes obtained by in vivo perfusion separation of the existing method, and the dye used in the PC5.5 channel is 7-AAD (living cells are 7-AAD-negative);

[0029] Figure 2 The figure is a comparison of the cell morphology of mouse liver cells obtained by ex vivo perfusion separation of the present invention and mouse liver cells obtained by in vivo perfusion separation of the existing method; wherein A is the mouse liver cell obtained by ex vivo perfusion separation of the present invention, and B is the mouse liver cell obtained by in vivo perfusion separation of the existing method. DETAILED DESCRIPTION

[0030] In order to enable those skilled in the art to understand the characteristics and effects of the present invention, the following is a general description and definition of the terms and expressions mentioned in the specification and claims. Unless otherwise specified, all technical and scientific terms used in the text are the common meanings understood by those skilled in the art for the present invention. In the event of a conflict, the definition in this specification shall prevail.

[0031] The theories or mechanisms described and disclosed herein, whether correct or incorrect, should not limit the scope of the present invention in any way, that is, the present invention can be implemented without being limited by any specific theory or mechanism.

[0032] Herein, all features such as values, quantities, contents and concentrations defined in the form of numerical ranges or percentage ranges are for simplicity and convenience only. Accordingly, the description of numerical ranges or percentage ranges should be considered to have included and specifically disclosed all possible secondary ranges and individual values ​​within the range (including integers and fractions).

[0033] In this document, unless otherwise specified, “includes,” “including,” “contains,” “has,” or similar terms cover the meanings of “consisting of” and “mainly consisting of,” for example, “A includes a” covers the meanings of “A includes a and other” and “A only includes a.”

[0034] In this document, in order to make the description concise, not all possible combinations of various technical features in various embodiments or examples are described. Therefore, as long as there is no contradiction in the combination of these technical features, the various technical features in various embodiments or examples can be combined arbitrarily, and all possible combinations should be considered to be within the scope of this specification.

[0035] In the specification of the present invention and the following examples, unless otherwise specified, "%" means volume percentage.

[0036] In this article, the formulas of some solutions used are as follows:

[0037] EGTA solution: Add 1190 mg of HEPES (Beyotime, ST090-100 g), 95 mg of EGTA and 1% antibiotics (penicillin 100 U / mL, streptomycin 100 μg / mL) to 500 mL of HBSS (Hanks' Balanced Salt Solution, Beyotime, Catalog No. C0218) buffer and mix well to obtain EGTA solution. Preheat to 40°C for later use.

[0038] Type I collagenase digestion solution: Add 1190 mg of HEPES (Beyotime, ST090-100g) and 280 mg of CaCl2 to 500 mL of HBSS (Hanks' Balanced Salt Solution, Beyotime, Catalog No. C0218) buffer, mix well, and preheat in a water bath to obtain tissue digestion buffer. Add 5 mg of collagenase I (Sigma-Aldrich, C0130-1G) to each 10 mL of tissue digestion buffer to obtain type I collagenase digestion solution. Preheat at 40°C and set aside.

[0039] DNase I solution: 20 mg DNase I (Roche, 10104159001) was added to 10 mL GBSS (Gey's Balanced Salt Solution, Livning, C1076-A) to fully dissolve to obtain DNase I solution, which was stored at -20°C. When used, in order to dilute the DNase I solution to its working concentration, GBSS or other buffers, digestion solutions, etc. were used to further dilute the above DNase I solution to 100 times the original volume.

[0040] The present invention provides a method for obtaining mouse hepatocytes, comprising the following steps:

[0041] 1. Preparation

[0042] 1) Preheat collagenase type I digestion solution to 40°C;

[0043] 2) Anesthetize the mouse and fully expose the liver.

[0044] 2. Mouse Liver Perfusion

[0045] 1) Cut open the inferior vena cava of mice and bleed them;

[0046] 2) Cut off the mouse liver, and try to keep the mouse liver intact;

[0047] 3) Clamp the mouse hepatic arteriovenous plexus with forceps or hemostats;

[0048] 4) The isolated mouse liver was perfused with type I collagenase digestion solution. When perfusing each lobe of the liver, the needle was inserted into the middle of each lobe of the mouse liver to about 1 / 2 of the thickness of the lobe of the liver and perfusion was continued until the mouse liver turned obviously white by naked eye, and digestion was stopped.

[0049] 3. Cut the mouse liver into pieces

[0050] In a mixture of type I collagenase digestion solution and DNase I solution, excess tissue (including gallbladder and liver capsule) of the whitened mouse liver was removed, and the remaining liver tissue was fully minced until no obvious tissue blocks were visible to the naked eye, thereby obtaining a tissue suspension.

[0051] 4. Mouse Liver Digestion

[0052] Transfer the tissue suspension into a mixture of type I collagenase digestion solution and DNase I solution, shake on a 40°C, 150 rpm platform, and digest for 10 min. If multiple livers are isolated at the same time, the cells can be placed at 4°C first, and other operations can be performed simultaneously.

[0053] 5. Mouse Hepatocyte Isolation

[0054] Filter the cells and collect the filtrate; at the same time, fully grind the undigested tissue to fully filter the cells; centrifuge the filtered cells, repeat the steps of adding DNase I solution and DMEM for centrifugation and washing twice, discard the supernatant, keep the precipitate, and culture it with DMEM containing 10% FBS and 3% antibiotics to obtain mouse hepatocytes.

[0055] The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms fall within the scope limited by the appended claims of the application equally.

[0056] The following examples use conventional instruments and equipment in the art. The experimental methods in the following examples without specifying specific conditions are usually carried out under conventional conditions or under conditions recommended by the manufacturer. The various raw materials used in the following examples, unless otherwise specified, are conventional commercial products, and their specifications are conventional specifications in the art.

[0057] Example 1 Isolation of mouse hepatocytes by in vitro perfusion

[0058] 1. Preparation

[0059] 1) Preheat collagenase type I digestion solution to 40°C;

[0060] 2) The mice were anesthetized by intraperitoneal injection, with the injection dose being 0.1 mg ketamine + 0.01 mg xylazine per gram of body weight of each mouse; after the mice were anesthetized, their abdominal cavities were opened and the livers were fully exposed.

[0061] 2. Mouse Liver Perfusion

[0062] 1) Cut open the inferior vena cava of mice and bleed them;

[0063] 2) Cut off the mouse liver, and try to keep the mouse liver intact;

[0064] 3) Clamp the mouse hepatic arteriovenous plexus with hemostatic forceps;

[0065] 4) Use a 5mL syringe with a 30G syringe needle to absorb the preheated type I collagenase digestion solution and perfuse each lobe of the isolated mouse liver. During perfusion, the syringe needle is inserted into the middle part of each lobe of the mouse liver, and the penetration depth is about 1 / 2 of the thickness of the liver. The amount of type I collagenase digestion solution required for each lobe of the mouse liver is 1.2mL, until the mouse liver turns obviously white by naked eye observation. Each perfusion of each lobe of the liver takes about 10 seconds, and a total of about 50 seconds; stop digestion.

[0066] 3. Cut the mouse liver into pieces

[0067] Place the mouse liver in a 6-well plate containing a mixture of 3mL I collagenase digestion solution and 30μL DNase I solution; cut off excess tissue such as the mouse gallbladder, clamp the perfused mouse liver with tweezers, remove the mouse liver capsule, transfer the remaining mouse liver to a 2mL EP tube, and use scissors to fully chop the remaining mouse liver until no obvious tissue blocks are visible to the naked eye, which takes about 2 minutes to obtain a tissue suspension.

[0068] 4. Mouse Liver Digestion

[0069] Transfer the chopped mouse liver tissue and the tissue suspension in the 6-well plate into a 50 mL tube containing a mixture of 20 mL of type I collagenase digestion solution and 200 μL of DNase I solution, shake at 40°C, 150 rpm, and digest for 10 minutes. If multiple livers are separated at the same time, the cells can be placed at 4°C first, and other operations can be performed simultaneously.

[0070] 5. Mouse Hepatocyte Isolation

[0071] 1) Filter the cells with a 70 μm filter and collect the cell filtrate; and gently press and grind the remaining undigested tissue with a 5 mL syringe needle plug. During the process, rinse the cell filter and well plate with DMEM culture medium to fully filter the cells;

[0072] 2) Centrifuge the filtered cells at 500 rpm (50 g) and 4°C for 3 min;

[0073] 3) Remove the supernatant (retain 10 mL), add DMEM to 30 mL, add 300 μL of DNase I solution, centrifuge at 500 rpm (50 g), 4°C for 3 min, and wash the cells once;

[0074] 4) Resuspend the cells in 10 mL of supernatant, add 300 μL of DNase I solution and DMEM to 30 mL; centrifuge at 500 rpm (50 g) at 4°C for 3 min, and wash the cells again;

[0075] 5) The supernatant was discarded, and the precipitate was kept and cultured with DMEM containing 10% FBS and 3% antibiotics (penicillin 300 U / mL, streptomycin 300 μg / mL) to obtain mouse hepatocytes.

[0076] Comparative Example 1: In vivo perfusion separation of mouse hepatocytes

[0077] 1. Preparation

[0078] 1) Preheat EGTA solution and type I collagenase digestion solution to 40°C respectively;

[0079] 2) The mice were anesthetized by intraperitoneal injection, with the injection dose being 0.1 mg ketamine + 0.01 mg xylazine per gram of body weight of each mouse; after the mice were anesthetized, their abdominal cavities were opened, and the liver, especially the portal vein and the inferior vena cava, were fully exposed.

[0080] 2. Mouse Liver Perfusion

[0081] 1) Use a vascular clamp to close the suprahepatic segment of the mouse inferior vena cava;

[0082] 2) Insert a 24G indwelling needle into the mouse portal vein and connect the 24G indwelling needle to the perfusion tube and the peristaltic pump. Before connecting the perfusion line, the tube should be filled with preheated EGTA solution to ensure that no bubbles are generated, which will lead to inadequate digestion of the mouse liver.

[0083] 3) Perfuse the liver with EGTA solution, cut the inferior vena cava at the same time, and perfuse for 3 to 5 minutes (flow rate 5 mL / min);

[0084] 4) After the mouse liver turns white, change to preheated type I collagenase digestion solution and continue perfusion at a perfusion rate of 5 mL / min. The type I collagenase digestion solution is perfused until the mouse liver capsule begins to expand and transparent cracks appear, until a small hole is left when the mouse liver is lightly touched with tweezers. The digestion is completed, which takes about 3 to 5 minutes. The entire perfusion process lasts for about 10 minutes after the peristaltic pump is turned on, and the digestion is stopped.

[0085] 3. Cut the mouse liver into pieces

[0086] Cut the mouse liver after perfusion and place it in a 6-well plate filled with collagenase-DNase digestion solution; remove excess tissue such as the mouse gallbladder, clamp the mouse liver after perfusion with tweezers, tear off the liver capsule, transfer the remaining mouse liver to a 2mL EP tube, and cut the remaining mouse liver with scissors until no obvious tissue blocks are visible to the naked eye. This takes about 2 minutes to obtain a tissue suspension.

[0087] 4. Mouse Hepatocyte Isolation

[0088] 1) Filter the tissue suspension with a 70 μm filter to collect the cell filtrate; and gently press and grind the remaining undigested tissue with a 5 mL syringe needle plug. During the process, rinse the cell filter and well plate with DMEM culture medium to fully filter the cells;

[0089] 2) Centrifuge the filtered cells at 500 rpm (50 g) for 3 min (4°C);

[0090] 3) Remove the supernatant (retain 10 mL), add DMEM to 30 mL, add 300 μL of DNase I solution, centrifuge at 500 rpm (50 g), 4°C for 3 min, and wash the cells once;

[0091] 4) Resuspend the cells in 10 mL of supernatant, add 300 μL of DNase I solution and DMEM to 30 mL; centrifuge at 500 rpm (50 g) at 4°C for 3 min, and wash the cells again;

[0092] 5) The supernatant was discarded, and the precipitate was kept and cultured with DMEM containing 10% FBS and 3% antibiotics (penicillin 300 U / mL, streptomycin 300 μg / mL) to obtain mouse hepatocytes.

[0093] Detection and microscopic examination of mouse liver cell viability obtained from the embodiment group and the comparative example group

[0094] 1. After separating the mouse liver cells collected from each group, wash the cells twice with pre-cooled PBS, centrifuge at 500g for 5min (4°C), and collect the cells;

[0095] 2. Resuspend the cells with 400 μL of PBS, add 7-AAD (i.e., 7-aminoactinomycin D) to a final concentration of 2.5 μM, and detect on a flow cytometer;

[0096] Test results such as Figure 1 As shown, the mouse hepatocytes isolated by ex vivo perfusion were obtained by this method ( Figure 1 The 7AAD negative rate of the mouse hepatocytes obtained by in vivo perfusion ( Figure 1 The 7AAD negative rate in middle B) was 76.40%, with no significant difference between the two groups.

[0097] 3. After mouse hepatocytes were cultured in DMEM complete medium until they were completely adhered to the wall for 3 days, the morphology of mouse hepatocytes in each group was observed under a microscope and photographed.

[0098] The results are as follows Figure 2 As shown, the mouse hepatocytes isolated by ex vivo perfusion were obtained by this method ( Figure 2 A) and mouse hepatocytes obtained by in vivo perfusion using existing methods ( Figure 2 B) No significant difference.

[0099] The above contents are only for explaining the technical idea of ​​the present invention and cannot be used to limit the protection scope of the present invention. Any changes made on the basis of the technical solution in accordance with the technical idea proposed by the present invention shall fall within the protection scope of the claims of the present invention.

Claims

1. A method for obtaining mouse hepatocytes, characterized in that: The following steps are involved: 1) perfusing an isolated mouse liver until the mouse liver turns white, thereby obtaining a whitened mouse liver; 2) digesting the blanched mouse liver to obtain digested mouse liver tissue; 3) The digested mouse liver tissue is separated and the precipitate is collected by centrifugation to obtain mouse hepatocytes.

2. A method for obtaining mouse hepatocytes according to claim 1, characterized in that: In step 1), before perfusion, the hepatic arteriovenous plexus of the mouse was clamped.

3. A method for obtaining mouse hepatocytes according to claim 1, characterized in that: In step 1), the perfusion fluid is type I collagenase digestion fluid.

4. A method for obtaining mouse hepatocytes according to claim 1, characterized in that: In step 1), the perfusion solution is perfused into the middle part of each lobe of the isolated mouse liver.

5. The method for obtaining mouse liver cells according to claim 3, characterized in that: In step 1), perfusion is performed using a syringe, and the insertion depth of the syringe is 1 / 2 of the thickness of the liver lobe.

6. A method for obtaining mouse hepatocytes according to any one of claims 1 to 5, characterized in that: In step 2), before digestion, the excess tissue of the blanched mouse liver is removed, and the remaining liver tissue is fully minced until no obvious tissue pieces are visible to the naked eye.

7. A method for obtaining mouse hepatocytes according to claim 6, characterized in that: In step 2), the excess tissue of the bleached mouse liver is removed in a mixture of type I collagenase digestion solution and DNase I solution, and the remaining liver tissue is fully minced until no obvious tissue blocks are visible to the naked eye.

8. A method for obtaining mouse hepatocytes according to any one of claims 1 to 5, characterized in that: In step 2), the blanched mouse liver is digested with a mixture of type I collagenase digestion solution and DNase I solution.

9. A method for obtaining mouse hepatocytes according to claim 8, characterized in that: In step 2), in the mixed solution, the volume ratio of type I collagenase digestion solution to DNase I solution is 100:

1.

10. A method for obtaining mouse hepatocytes according to any one of claims 1 to 5, characterized in that: In step 3), the separation step is: centrifuge to remove the supernatant, repeat the steps of adding DMEM and DNase I solution, centrifuge and wash, discard the supernatant, keep the precipitate, and obtain mouse hepatocytes.